Table of Content



Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
5.1 Market variable Analysis
5.1.1 Rising incidence of cancer and cardiovascular diseases
5.1.2 Increasing application of radiopharmaceuticals
5.1.3 Growing demand for accurate diagnostic methods
5.1.4 Market Restraint Analysis
5.1.4.1 Stringent regulations pertaining to production, storage, & usage
5.1.4.2 High costs associated with diagnostics & therapeutic procedures
Chapter 6 Business Environment Analysis
6.1.1 SWOT Analysis; By factor (POLITICAL & Legal, economic and technological)
6.1.2 Porter’s five forces analysis
6.1.3 Value chain analysis
Chapter 7 Regulatory and Political Forces
7.1 Regulatory Landscape
7.1.1 List of factors/ regulations by country
7.1.1.1 North America
7.1.1.1.1 U.S.
7.1.1.1.2 Canada
7.1.1.2 Europe
7.1.1.2.1 Germany
7.1.1.2.2 U.K.
7.1.1.2.3 France
7.1.1.2.4 Italy
7.1.1.2.5 Spain
7.1.1.2.6 Russia
7.1.1.2.7 Netherlands
7.1.1.3 Asia Pacific
7.1.1.3.1 China
7.1.1.3.2 Japan
7.1.1.3.3 India
7.1.1.3.4 Australia
7.1.1.3.5 New Zealand
7.1.1.3.6 South Korea
7.1.1.3.7 Singapore
7.1.1.3.8 Malaysia
7.1.1.3.9 Philippines
7.1.1.4 Latin America
7.1.1.4.1 Brazil
7.1.1.4.2 Mexico
7.1.1.4.3 Argentina
7.1.1.5 Middle East & Africa
7.1.1.5.1 South Africa
7.1.1.5.2 GCC
7.2 Production Process And Trends
7.2.1 Production of molybdenum-99 (SPECT radioisotopes)
7.2.1.1 SPECT radioisotopes trends
7.2.1.2 PET radioisotopes Trends
7.2.1.3 Therapeutic radioisotopes trends
7.2.1.4 Latest Developments
Chapter 8 Competitive Analysis
8.1 Vendor Landscape
8.1.1 List of key distributors and channel partners
8.1.2 Key company market share analysis, 2019
8.2 Public Companies
8.2.1 Company market position analysis
8.2.2 Competitive Dashboard Analysis
8.3 Private Companies
8.3.1 List of key emerging companies /technology disruptors/innovators
8.3.2 Regional network map
Chapter 9 Product Business Analysis
9.1 Radiopharmaceuticals/Nuclear Medicine Market: Product Movement Analysis
9.2 Diagnostic Products
9.2.1 Diagnostic products market, 2016 - 2027 (USD Million)
9.2.1.1 SPECT
9.2.1.1.1 SPECT products market, 2016 - 2027 (USD Million)
9.2.1.1.2 TC-99m
9.2.1.1.3 TC-99m market, 2016 - 2027 (USD Million)
9.2.1.1.4 TL-201
9.2.1.1.5 TL-201 market, 2016 - 2027 (USD Million)
9.2.1.1.6 GA-67
9.2.1.1.7 GA-67 market, 2016 - 2027 (USD Million)
9.2.1.1.8 I-123
9.2.1.1.9 I-123 market, 2016 - 2027 (USD Million)
9.2.1.1.10 Other SPECT products
9.2.1.1.11 Other SPECT products market, 2016 - 2027 (USD Million)
9.2.1.2 PET
9.2.1.2.1 PET products market, 2016 - 2027(USD Million)
9.2.1.2.2 F-18
9.2.1.2.3 F-18 market, 2016 - 2027 (USD Million)
9.2.1.2.4 SR-82/RB-82
9.2.1.2.5 SR-82/RB-82 market, 2016 - 2027 (USD Million)
9.2.1.2.6 Other PET products
9.2.1.2.7 Other PET products market, 2016 - 2027 (USD Million)
9.3 Therapeutic Products
9.3.1 Therapeutic products market, 2016 - 2027 (USD Million)
9.3.2 Alpha emitters
9.3.2.1 Alpha emitters market, 2016 - 2027 (USD Million)
9.3.2.1.1 RA-223
9.3.2.1.1.1 RA-223 market, 2016 - 2027 (USD Million)
9.3.2.1.2 Other alpha emitters
9.3.2.1.3 Other alpha emitters market, 2016 - 2027 (USD Million)
9.3.3 Beta emitters
9.3.3.1 Beta emitters market, 2016 - 2027 (USD Million)
9.3.3.2 I-131
9.3.3.2.1 I-131 market, 2016 - 2027 (USD Million)
9.3.3.3 Y-90
9.3.3.3.1 Y-90 market, 2016 - 2027 (USD Million)
9.3.3.4 SM-153
9.3.3.4.1 SM-153 market, 2016 - 2027 (USD Million)
9.3.3.5 Re-186
9.3.3.5.1 Re-186 market, 2016 - 2027 (USD Million)
9.3.3.6 Lu-117
9.3.3.6.1 Lu-177 market, 2016 - 2027 (USD Million)
9.3.3.7 Other beta emitters
9.3.3.7.1 Other beta emitters market, 2016 - 2027 (USD Million)
9.3.4 Brachytherapy
9.3.4.1 Brachytherapy market, 2016 - 2027 (USD Million)
9.3.4.2 Cesium-131
9.3.4.2.1 Cesium-131 market, 2016 - 2027 (USD Million)
9.3.4.3 Iodine-125
9.3.4.3.1 Iodine-125 market, 2016 - 2027 (USD Million)
9.3.4.4 Palladium-103
9.3.4.4.1 Palladium-103 market, 2016 - 2027 (USD Million)
9.3.4.5 Iridium-192
9.3.4.5.1 Iridium-192 market, 2016 - 2027 (USD Million)
9.3.4.6 Other brachytherapy products
9.3.4.6.1 Other brachytherapy products market, 2016 - 2027 (USD Million)
Chapter 10 Application Mode Business Analysis
10.1 Radiopharmaceuticals/Nuclear Medicine Market: Application Movement Analysis
10.1.1 Cardiology
10.1.1.1 Cardiology applications market, 2016 - 2027 (USD Million)
10.1.2 Neurology
10.1.2.1 Neurology applications market, 2016 - 2027 (USD Million)
10.1.3 Oncology
10.1.3.1 Oncology applications market, 2016 - 2027 (USD Million)
10.1.4 Thyroid
10.1.4.1 Thyroid applications market, 2016 - 2027 (USD Million)
10.1.5 Lymphoma
10.1.5.1 Lymphoma applications market, 2016 - 2027 (USD Million)
10.1.6 Bone metastasis
10.1.6.1 Bone metastasis applications market, 2016 - 2027 (USD Million)
10.1.7 Endocrine tumor
10.1.7.1 Endocrine tumor market, 2016 - 2027 (USD Million)
10.1.8 Other application
10.1.8.1 Other applications market, 2016 - 2027 (USD Million)
Chapter 11 Regional Business Analysis
11.1 Radiopharmaceuticals/Nuclear Medicine Market: Regional Movement Analysis
11.2 North America
11.2.1 North America Market Estimates And Forecast, 2016 - 2027
11.2.2 U.S.
11.2.2.1 U.S. Market Estimates And Forecast, 2016 - 2027
11.2.3 Canada
11.2.3.1 Canada Market Estimates And Forecast, 2016 - 2027
11.3 Europe
11.3.1 Europe Market Estimates And Forecast, 2016 - 2027
11.3.2 Germany
11.3.2.1 Germany Market Estimates And Forecast, 2016 - 2027
11.3.3 U.K.
11.3.3.1 U.K. Market Estimates And Forecast, 2016 - 2027
11.3.4 France
11.3.4.1 France Market Estimates And Forecast, 2016 - 2027
11.3.5 Italy
11.3.5.1 Italy Market Estimates And Forecast, 2016 - 2027
11.3.6 Spain
11.3.6.1 Spain Market Estimates And Forecast, 2016 - 2027
11.3.7 Russia
11.3.7.1 Russia Market Estimates And Forecast, 2016 - 2027
11.3.8 Netherlands
11.3.8.1 Netherlands Market Estimates And Forecast, 2016 - 2027
11.4 Asia Pacific
11.4.1 Asia Pacific Market Estimates And Forecast, 2016 - 2027
11.4.2 Japan
11.4.2.1 Japan Market Estimates And Forecast, 2016 - 2027
11.4.3 China
11.4.3.1 China Market Estimates And Forecast, 2016 - 2027
11.4.4 India
11.4.4.1 India Market Estimates And Forecast, 2016 - 2027
11.4.5 Australia
11.4.5.1 Australia Market Estimates And Forecast, 2016 - 2027
11.4.6 Singapore
11.4.6.1 Singapore Market Estimates And Forecast, 2016 - 2027
11.4.7 Malaysia
11.4.7.1 Malaysia Market Estimates And Forecast, 2016 - 2027
11.4.8 New Zealand
11.4.8.1 New Zealand Market Estimates And Forecast, 2016 - 2027
11.4.9 South Korea
11.4.9.1 South Korea Market Estimates And Forecast, 2016 - 2027
11.4.10 Philippines
11.4.10.1 Philippines Market Estimates And Forecast, 2016 - 2027
11.5 Latin America
11.5.1 Latin America Market Estimates And Forecast, 2016 - 2027
11.5.2 Brazil
11.5.2.1 Brazil Market Estimates And Forecast, 2016 - 2027
11.5.3 Mexico
11.5.3.1 Mexico Market Estimates And Forecast, 2016 - 2027
11.5.4 Argentina
11.5.4.1 Argentina Market Estimates And Forecast, 2016 - 2027
11.6 Middle East & Africa
11.6.1 Middle-East And Africa Market Estimates And Forecast, 2016 - 2027
11.6.2 Saudi Arabia
11.6.2.1 Saudi Arabia Market Estimates And Forecast, 2016 - 2027
11.6.3 South Africa
11.6.3.1 South Africa Market Estimates And Forecast, 2016 - 2027
11.6.4 Israel
11.6.4.1 Israel Market Estimates And Forecast, 2016 - 2027
11.6.5 Turkey
11.6.5.1 Turkey Market Estimates And Forecast, 2016 - 2027
Chapter 12 Company Profile
12.1 Eckert & Ziegler
12.1.1.1 Company overview
12.1.1.2 Financial performance
12.1.1.3 Product benchmarking
12.1.1.4 Strategic initiatives
12.2 Mallinckrodt
12.1.2.1 Company overview
12.1.2.2 Financial performance
12.1.2.3 Product benchmarking
12.1.2.4 Strategic initiatives
12.3 Curium Pharma
12.1.3.1 Company overview
12.1.3.2 Product benchmarking
12.1.3.3 Strategic initiatives
12.4 GE Healthcare
12.1.4.1 Company overview
12.1.4.2 Financial performance
12.1.4.3 Product benchmarking
12.1.4.4 Strategic initiatives
12.5 Jubilant Pharma. LLC
12.1.5.1 Company overview
12.1.5.2 Financial performance
12.1.5.3 Product benchmarking
12.1.5.4 Strategic initiatives
12.6 Bracco Imaging S.p.A
12.1.6.1 Company overview
12.1.6.2 Product benchmarking
12.1.6.3 Strategic initiatives
12.7 Nordion (Canada) Inc.
12.1.7.1 Company overview
12.1.7.2 Financial performance
12.1.7.3 Product benchmarking
12.1.7.4 Strategic initiatives
12.8 The Institute for Radioelements (IRE - IRE ELiT)
12.1.8.1 Company overview
12.1.8.2 Financial performance
12.1.8.3 Product benchmarking
12.1.8.4 Strategic initiatives
12.9 Australian Nuclear Science & Technology Organization (ANSTO)
12.1.9.1 Company overview
12.1.9.2 Financial performance
12.1.9.3 Product benchmarking
12.1.9.4 STRATEGIC INITIATIVES
12.10 NTP Radioisotopes SOC Ltd.
12.1.10.1 Company overview
12.1.10.2 Financial performance
12.1.10.3 Product benchmarking
12.1.10.4 Strategic initiatives
12.11 Eczacibasi-Monrol
12.1.11.1 Company overview
12.1.11.2 Financial performance
12.1.11.3 Product benchmarking
12.1.11.4 Strategic initiatives
12.12 Lantheus Medical Imaging, Inc.
12.1.12.1 Company overview
12.1.12.2 Financial overview
12.1.12.3 Product benchmarking
12.1.12.4 Strategic initiatives




List of Tables



Table 1 List of Abbreviation
Table 2 Global producers of Mo-99
Table 3 New projects expected to produce Mo-99
Table 4 List of key distributors
Table 5 List of key emerging companies /technology disruptors/innovators
Table 6 North America Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 7 North America Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 8 North America Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 9 North America Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 10 North America Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 11 North America Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 12 North America Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 13 North America Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 14 North America Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 15 U.S. Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 16 U.S. Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 17 U.S. Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 18 U.S. Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 19 U.S. Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 20 U.S. Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 21 U.S. Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 22 U.S. Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 23 U.S. Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 24 Canada Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 25 Canada Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 26 Canada Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 27 Canada Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 28 Canada Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 29 Canada Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 30 Canada Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 31 Canada Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 32 Canada Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 33 Europe Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 34 Europe Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 35 Europe Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 36 Europe Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 37 Europe Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 38 Europe Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 39 Europe Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 40 Europe Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 41 Europe Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 42 Germany Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 43 Germany Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table44 Germany Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 45 Germany Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 46 Germany Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 47 Germany Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 48 Germany Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 49 Germany Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 50 Germany Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 51 U.K. Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 52 U.K. Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 53 U.K. Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 54 U.K. Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 55 U.K. Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 56 U.K. Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 57 U.K. Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 58 U.K. Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 59 U.K. Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 60 France Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 61 France Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 62 France Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 63 France Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 64 France Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 65 France Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 66 France Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 67 France Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 68 France Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 69 Italy Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 70 Italy Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 71 Italy Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 72 Italy Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 73 Italy Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 74 Italy Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 75 Italy Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 76 Italy Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 77 Italy Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 78 Spain Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 79 Spain Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 80 Spain Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 81 Spain Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 82 Spain Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, by Product, 2016 - 2027 (USD Million)
TABLE 83 Spain Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 84 Spain Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 85 Spain Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 86 Spain Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 87 Russia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 88 Russia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 89 Russia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 90 Russia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 91 Russia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 92 Russia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 93 Russia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 94 Russia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 95 Russia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 96 Netherlands Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 97 Netherlands Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 98 Netherlands Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 99 Netherlands Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 100 Netherlands Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 101 Netherlands Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 102 Netherlands Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 103 Netherlands Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 104 Netherlands Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 105 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 106 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 107 Asia Pacific Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 108 Asia Pacific Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 109 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 111 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 112 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 113 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 114 Asia Pacific Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 115 Japan Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 116 Japan Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 117 Japan Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 118 Japan Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 119 Japan Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 120 Japan Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 121 Japan Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 122 Japan Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 123 Japan Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 124 China Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 125 China Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 126 China Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 127 China Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 – 2027 (USD Million)
TABLE 128 China Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 129 China Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 130 China Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 131 China Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 132 China Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 133 India Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 134 India Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 135 India Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 136 India Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 137 India Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 138 India Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 139 India Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 140 India Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 141 India Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 142 Australia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 143 Australia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 144 Australia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 145 Australia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 146 Australia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 147 Australia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 148 Australia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 149 Australia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 150 Australia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 151 Singapore Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 152 Singapore Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 153 Singapore Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 154 Singapore Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 155 Singapore Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 156 Singapore Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 157 Singapore Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 158 Singapore Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 159 Singapore Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 160 Malaysia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 161 Malaysia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 162 Malaysia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 163 Malaysia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 164 Malaysia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 165 Malaysia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 166 Malaysia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 167 Malaysia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 168 Malaysia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 169 New Zealand Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 170 New Zealand Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 171 New Zealand Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 172 New Zealand Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 173 New Zealand Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 174 New Zealand Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 175 New Zealand Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 176 New Zealand Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 177 New Zealand Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 178 South Korea Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 179 South Korea Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 180 South Korea Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 181 South Korea Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 182 South Korea Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 183 South Korea Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 184 South Korea Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 185 South Korea Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 186 South Korea Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 187 Philippines Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 188 Philippines Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 189 Philippines Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 190 Philippines Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 191 Philippines Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 192 Philippines Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 193 Philippines Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 194 Philippines Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 195 Philippines Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 196 Latin America Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 197 Latin America Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 198 Latin America Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 199 Latin America Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 200 Latin America Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 201 Latin America Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 202 Latin America Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 203 Latin America Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 204 Latin America Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 205 Brazil Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 206 Brazil Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 207 Brazil Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 208 Brazil Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 209 Brazil Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 210 Brazil Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 211 Brazil Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 212 Brazil Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 213 Brazil Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 214 Mexico Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 215 Mexico Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 216 Mexico Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 217 Mexico Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 218 Mexico Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 219 Mexico Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 220 Mexico Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 221 Mexico Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 222 Mexico Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 223 Argentina Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 224 Argentina Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 225 Argentina Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 226 Argentina Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016–2027 (USD Million)
TABLE 227 Argentina Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 228 Argentina Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 229 Argentina Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 230 Argentina Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 231 Argentina Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 232 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 233 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 234 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 235 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 236 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 237 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 238 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 239 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 240 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 241 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 242 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 243 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product2016 - 2027 (USD Million)
TABLE 244 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 245 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 246 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 247 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 248 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 249 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 250 South Africa Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 251 South Africa Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 252 South Africa Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 253 South Africa Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 254 South Africa Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 255 South Africa Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 256 South Africa Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 257 South Africa Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 258 South Africa Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 259 Israel Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 260 Israel Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 261 Israel Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 262 Israel Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 263 Israel Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 264 Israel Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 265 Israel Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 266 Israel Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 267 Israel Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)
Table 268 Turkey Nuclear Medicine/Radiopharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
Table 269 Turkey Nuclear Medicine/Radiopharmaceuticals Diagnostic Market, By Product, 2016 - 2027 (USD Million)
Table 270 Turkey Nuclear Medicine/Radiopharmaceuticals SPECT Market, By Product, 2016 - 2027 (USD Million)
TABLE 271 Turkey Nuclear Medicine/Radiopharmaceuticals PET market, By Product, 2016 - 2027 (USD Million)
TABLE 272 Turkey Nuclear Medicine/Radiopharmaceuticals Therapeutic Market, By Product, 2016 - 2027 (USD Million)
TABLE 273 Turkey Nuclear Medicine/Radiopharmaceuticals Alpha emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 274 Turkey Nuclear Medicine/Radiopharmaceuticals Beta emitters Market, By Product, 2016 - 2027 (USD Million)
TABLE 275 Turkey Nuclear Medicine/Radiopharmaceuticals Brachytherapy Market, By Product, 2016 - 2027 (USD Million)
Table 276 Turkey Nuclear Medicine/Radiopharmaceuticals, By Application, 2016 - 2027 (USD Million)